Pharmascience Canada is proud to announce the launch of Pr pms-RUPATADINE (rupatadine), a treatment that helps relieve nasal and non-nasal symptoms of seasonal allergic rhinitis (SAR) and perennial ...

Medically reviewed by Brendan Camp, MD Hives and eczema are two of the most common skin disorders. Hives, clinically known as ...

Hives, also known as urticaria, are raised, itchy welts on your skin that occur due to an allergen. The reaction is uncomfortable, but it’s often not serious.

New allergies frequently pop up and their severities can change too – meaning Chloe has to keep track of them with a color-coded spreadsheet.

A young woman with more than 40 allergies - including water - has to use a colour-coded spreadsheet to keep track of them all ...

She has to keep track of whatever foods she reacts to, and how severely, using a traffic-light colour coded system on an ...

A year after reducing half of its workforce, Allakos will downsize to just 15 employees as it halts the development of AK006.

A Bay Area biotech firm is laying off 75% of its staff following a flopped clinical trial. Allakos, based in San Carlos, ...

Patients with chronic spontaneous urticaria see well-controlled ... substantial reductions in hives and itch with briquilimab through 16 weeks of treatment, with responses as early as week 1 ...

Celldex Therapeutics , Inc. (NASDAQ:CLDX), a biopharmaceutical company with a market capitalization of $1.6 billion focused on developing innovative therapies for challenging diseases, has been making ...

Urticarial vasculitis represents 5% to 10% of cases of chronic urticaria, characterized histologically by the presence of vasculitis on skin biopsy. Clinically it tends to last longer than ...

Novartis’ immunoglobulin E inhibitor Xolair has been a mainstay of treatment for chronic spontaneous urticaria (CSU ... causes welts (commonly known as ‘hives’) to spring up on the skin.